香港股市 將收市,收市時間:6 小時 6 分鐘

再鼎醫藥 (9688.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
16.560+0.360 (+2.22%)
市場開市。 截至 09:49AM HKT。
全螢幕
前收市價16.200
開市17.980
買盤16.400 x 無
賣出價16.420 x 無
今日波幅16.100 - 17.980
52 週波幅10.560 - 28.250
成交量2,935,400
平均成交量4,911,388
市值16.348B
Beta 值 (5 年,每月)1.11
市盈率 (最近 12 個月)
每股盈利 (最近 12 個月)-2.740
業績公佈日2024年8月05日 - 2024年8月09日
遠期股息及收益率無 (無)
除息日
1 年預測目標價39.07
  • Insider Monkey

    Zai Lab Limited (NASDAQ:ZLAB) Q1 2024 Earnings Call Transcript

    Zai Lab Limited (NASDAQ:ZLAB) Q1 2024 Earnings Call Transcript May 9, 2024 Zai Lab Limited isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, ladies and gentlemen, thank you for standing by and welcome to Zai Lab’s First Quarter 2024 […]

  • PR Newswire Asia

    再鼎醫藥公佈2024年第一季度財務業績和近期公司進展

    再鼎醫藥公佈2024年第一季度財務業績和近期公司進展

  • InvestorPlace

    Shhh! 7 Small-Cap Stocks That Can Double by 2025

    Small cap stocks like those discussed below tend to receive much less attention than their large cap competitors. Shares, which boast a market capitalization between $250 million and $2 billion, remain relatively small. The largest stocks including Nvidia (NASDAQ:NVDA) and Microsoft (NASDAQ:MSFT) are valued into the trillions. It’s no surprise then that they receive the lion’s share of investor attention and capital. As a result, there are a lot of deals to be had among small-cap stocks. Investo